null
In Stock

Orbenin Enduro 600mg 3.6g Intramammary x 120 Syringes

Write a Review
$270.90
Orbenin Enduro
Orbenin Enduro
Current Stock:
Indication:
For the control of mastitis in dairy cows caused by Streptococcus spp, Staphylococcus spp.(including penicillin resistant strains), Corynebacterium spp. and other organisms susceptible to cloxacillin.
Contraindications:
Administration to lactating cows or cows expected to calve less than 35 days following treatment. Allergy to penicillins.
Manufacturer:
Zoetis
Trade Name:
Orbenin Enduro
Quantity:
3.6g
Refrigeration:
N/A
Active Ingredient:
Cloxacillin (as the benzathine salt) 600 mg
$270.90

Description

PRESCRIPTION REQUIRED FOR THIS ITEM

This item is a prescription medication. A prescription is required from your veterinarian before we can supply this product. Please ensure that you have read the "How to Order" page before ordering this item.

All of Pet Care Pharmacy’s prescription medications are APVMA or TGA approved and are also identical to those supplied by your veterinarian.

 

Orbenin® Enduro Dry Cow Intramammary Suspension is a stable suspension containing 600mg per syringe of cloxacillin as the benzathine salt in a long acting base.

 

It is presented in syringes for intramammary infusion and is designed to be used in the dairy cow at the point of drying off, immediately after the last milking of the lactation.

 

The combined effects of the relatively insoluble benzathine salt and the long acting base give an extended period of activity for 7-8 weeks in the dry cow.

For the control of mastitis in dairy cows caused by Streptococcus spp, Staphylococcus spp.(including penicillin resistant strains), Corynebacterium spp. and other organisms susceptible to cloxacillin.

Mastitis due to streptococci is still common but Staphylococcus spp, many strains of which are penicillin resistant, now account for a large proportion of cases. The extent of sub-clinical and latent infection in a herd is frequently unsuspected. Half the herd may well be affected, although a much smaller number show clinical signs at any one time. In untreated herds a significant build up of subclinical infection can occur during the dry period, so that after a number of lactations the incidence of infection becomes serious. The influence of sub-clinical infection on milk yield, the risk of cross-infection and the chance of sub-clinical infection flaring up, make it necessary to treat the matter as a herd problem.

Cows maybe selected at dry off to receive Orbenin® Enduro, or, if advised by a veterinarian a blanket of whole herd treatment may be warranted. When the cow is milked out for the last time the teat is sterilised and one syringe of Orbenin® Enduro Dry Cow Intramammary Suspension is infused into each quarter and allowed to remain. It is desirable to use an antiseptic teat dip and other routine hygienic measures at milking to help maintain the control of infection in the herd.

While cases of mastitis, if they arise during lactation, will still require treatment with an appropriate antibiotic such as Orbenin® LA, the use of the routine dry cow medication has been shown to achieve very valuable control of herd infection at calving. Since the treatment is during the dry period it does not lead to loss from discarded milk.

Dosage:

At the end of lactation milk the cow out normally. Clean and disinfect the teat, infuse one syringe of Orbenin® Enduro into each quarter. It is normally unnecessary and undesirable to introduce any further antibiotic treatment during the dry period. The cow will be milked as usual when she calves down.

Storage:

Store below 25°C (air conditioning)

Withholding period:

Meat:

DO NOT USE less than 30 days before slaughter for human consumption

Milk:

DO NOT USE in lactating cattle. DO NOT USE less than 35 days before calving. Milk from treated cows MUST NOT BE USED for human consumption for 96 hours (8 milkings) after calving.

If any cows calve less than 35 days after treatment, milk must not be used for human consumption within 21 days after calving.

If inadvertently administered to lactating cows, milk from treated cows must not be used for human consumption or supplied for processing for 21 days. This milk should not be fed to calves before 14 days after treatment.

 

Product Reviews